Abstract:
Objective
To analyze lessons and experiences of the failed cases of the recurrent bone cyst(BC)and aneurysmal bone cyst (BCA) by evaluations of the clinical efficacy and long-term follow-up results of local intralesional injection, as well as the therapeutic effect of subcutaneous injection of denosumab.
Methods
Retrospective analysis was performed on 10 patients with postoperative recurrence of BC and BCA in The First Affiliated Hospital of Guangzhou University of Chinese Medicine from 2013 to 2021. Five patients were treated with multiple intralesional injections after recurrence. Among these five patients, two patients were treated with denosumab, one patient was treated with epiphyseal plate block, and one patient finally underwent artificial hip replacement. These 10 patients were followed up for a long time to evaluate the clinical efficacy,oncological outcome and postoperative function.
Results
Some BCA and BC patients had no obvious clinical symptoms after recurrence. After at least 24 months of follow-up, all the patients treated with intralesional injection and desumumab achieved partial or complete healing, Musculoskeletal Tumor Society (MSTS) score of 29 or 30, good functional activity, high psychological acceptance, and no complication.
Conclusion
Regular follow-up is very important to detect recurrence of BCA and BC, and multiple intralesional injections are recommended for recurrent patients.
Key words:
Bone cyst,
Bone cysts, aneurismal,
Recurrence,
Injections, intralesional
Dun Zhao, Bin Fang, Chunzhi Yi, Yue Li. Experience in treatment of ten cases of para-articular recurrent bone cysts[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2024, 18(06): 808-812.